CTEV Claritev Corp Insider Trading

SVP Carol Nutter buys 875 CTEV shares at $28.41; stock now $29.74, down 59.8% from $74.07 high.

Carol Nutter, SVP and Chief People Officer, purchased 875 shares at $28.41, increasing her holdings to 46,941 shares. The purchase occurred during a period of significant stock weakness: CTEV trades $29.74 today, down 59.8% from its 52-week high of $74.07, though it has recovered 85.6% over the past 90 days. The company's financials show structural challenges—it reported a net loss of $-73.6M on quarterly revenue of $244.7M and remains unprofitable on a full-year basis, despite 3.7% annual revenue growth. An insider purchase by a people operations executive in a deeply underwater stock amid ongoing losses warrants attention to the company's financial trajectory and near-term cash requirements.

EVP/CDO buys 3,000 shares at $16.65 amid 78.2% decline from 52-week high; cluster of 3 insider buys in 14 days.

Kim Michael purchased 3,000 shares at $16.65, increasing holdings to 185.9K shares (+1.6%), while Claritev's stock has fallen -78.2% from its $74.07 52-week high and declined -21.5% over 30 days. The company posted a $-73.6M net loss against $244.7M quarterly revenue and remains unprofitable on a full-year basis. Michael's prior trades at Claritev show mixed results: 1 of 3 prior buys delivered positive 90-day returns, while the other two experienced declines or minimal gains. More significantly, this purchase is part of a cluster pattern with 2 other insiders also buying within the past 14 days, which may suggest coordinated or independent conviction responses to recent price weakness. The insider's cross-ticker track record (4 prior buys averaging +73.1% over 90 days) is materially stronger than his same-ticker history, indicating his timing signals may not reliably apply to Claritev specifically.

Director Prince John Michael bought 10,000 shares of CTEV at $16.00; stock down 78.2% from 52-week high, company unprofitable.

Prince John Michael purchased 10,000 shares at $16.00, increasing his holdings from 21,662 shares to 31,662 shares, a 46.2% increase in his position. The purchase occurs in the context of significant price deterioration: the stock trades at $16.17, down 78.2% from its 52-week high of $74.07 and down 21.5% over the prior 30 days. Claritev Corp reported a net loss of $-73.6M on revenue of $244.7M in its most recent quarter and was unprofitable over its most recent full fiscal year, raising questions about the company's underlying fundamentals. The director's accumulation of shares at a depressed price level against a backdrop of operational losses and negative price momentum warrants examination of whether this reflects confidence in a turnaround or other considerations.

CEO Dalton Travis buys 20,920 shares at $12.36 blended price; stock down 78.2% from 52-week high and -31.4% in 90 days.

Dalton Travis, Pres., CEO & Executive Chair, executed 2 separate purchases totaling 20,920 shares for $258,638.40 on 2026-05-18, bringing his holdings to 45,872 shares and raising his position by 83.8%. The purchases occurred at a blended average price of $12.36, during a period when the stock trades at $16.17 (current), down 78.2% from its 52-week high of $74.07 and down 31.4% over the past 90 days. At CTEV specifically, Travis has a mixed timing record: 4 of 5 prior buys showed positive 90-day returns, with his most recent buy on 2026-02-27 returning +19.6% over 30 days. However, his cross-ticker track record shows strong performance (85.71% win rate, avg 90d return +351.2% across 7 buys), raising the question of whether his timing skill translates to CTEV. The company itself is unprofitable (net income of $-73,560,000.00 in the latest quarter, negative full-year net income), with modest 3.7% annual revenue growth. The magnitude of this buy relative to his prior holdings and the sharp stock decline warrant attention to whether this reflects fundamental conviction or simply an accumulation during depressed valuation levels.

EVP&CFO Garis Douglas Michael bought 1,300 shares of CTEV at $17.69; 5 of 5 prior buys at this ticker well-timed at 90-day mark, yet stock down 75.8% from 52-week high.

Garis Douglas Michael's purchase of 1,300 shares at $17.69 follows a striking pattern: his prior 5 open-market buys at Claritev all delivered positive 90-day returns (ranging from +84.6% to +158.8%), indicating consistent skill in entry timing at this specific ticker. His cross-ticker track record is similarly impressive, with 8 prior buys averaging +789.9% over 90 days and a 100.00% win rate. However, context demands caution: the stock is now -75.8% from its 52-week high and -23.4% in just 30 days, Claritev reported net income of $-69.8M on revenue of $246.0M, and the company remains unprofitable on a full-year basis. This buy occurs within a 14-day cluster involving 2 other insiders, suggesting coordinated action, yet the fundamental backdrop—steep price decline, operating losses, and severely depressed valuation (P/E of 0.29)—makes this transaction a test of whether prior timing success extends into a deteriorating business environment.

EVP Kim Michael buys 15,000 CTEV shares at $16.50; stock down 75.8% from 52-week high; 2 other insiders bought within 14 days

Kim Michael, EVP Chief Digital Officer, purchased 15,000 shares of Claritev Corp at $16.50 on 2026-03-12, expanding his holdings from 167,878 to 182,878 shares. The purchase comes amid significant stock weakness: CTEV is trading at $17.60, down 75.8% from its 52-week high of $72.58 and down 23.4% over the past 30 days and 54.1% over 90 days. The company is unprofitable, reporting a negative net income of $-69.8M on revenue of $246.0M with a P/E ratio of 0.29. The transaction is notable for clustering: two other insiders also purchased shares within the past 14 days. Michael's prior buy at this ticker on 2025-11-17 generated a negative 90-day return of -39.9%, suggesting his historical timing at CTEV has not been favorable. Investors should note the concurrent insider activity alongside deteriorating fundamentals and sustained price decline.

SVP/General Counsel Tara O'Neil bought 750 CTEV shares at $12.99; stock now -80.1% from 52-week high, -46.9% in 30 days.

O'Neil purchased 750 shares at $12.99, adding to her 26,449-share holdings in a company that has lost -68.0% over 90 days and is trading -80.1% below its 52-week high of $72.58. The company is unprofitable with $-69.8M in net income against $246.0M in quarterly revenue, and the stock has declined -46.9% in just the past 30 days, suggesting acute deterioration. At this same ticker, O'Neil's prior buy on 2025-11-17 posted a -40.8% 90-day return, indicating her recent CTEV selections have not been well-timed; of her 2 prior buys at CTEV, only 1 achieved positive 90-day returns. The presence of 2 other insiders also buying within 14 days forms a cluster pattern, but this does not alter the fundamental context: the stock is in severe decline and this insider's timing history at CTEV suggests limited predictive value.

EVP Kim Michael bought 30,000 shares at $14.30; stock down 80.1% from 52-week high amid unprofitability and cluster buy activity.

Kim Michael, EVP and Chief Digital Officer, purchased 30,000 shares at $14.30, increasing holdings by 27.8% to 138.0K shares. The purchase occurs after significant price deterioration: the stock is down 80.1% from its 52-week high of $72.58 and down 68.0% over the past 90 days. Company fundamentals are concerning—net income was $-69.8M on revenue of $246.0M, with annual revenue growth of only 3.7%. At the same ticker, Michael's prior buy on 2025-11-17 resulted in a -39.9% 90-day return, indicating poor timing on his previous CTEV purchase. However, this transaction is part of a cluster pattern with 2 other insiders buying within the past 14 days, which may signal coordinated management action despite the stock's distressed valuation and continued unprofitability.

CEO Dalton Travis buys 15,380 shares at $13.00; stock down -80.1% from $72.58 52-week high; company unprofitable with -$69.8M net income

Dalton Travis, as President, CEO & Executive Chair, purchased 15,380 shares at $13.00 on 2026-02-27, increasing his holdings from 9,572 shares to 24,952 shares (+160.7% growth in his position). The transaction occurs while CTEV trades at $14.43, which is -80.1% from its 52-week high of $72.58, and the stock has declined -46.9% over 30 days and -68.0% over 90 days. Despite this dramatic drawdown, the company remains unprofitable with net income of -$69.8M on revenue of $245.9M. At the same-ticker level, Travis's prior four of five purchases showed positive 90-day returns (timing success rate of 80%), with his most recent CTEV buy on 2025-11-20 declining -50.1% over 90 days—a notable miss. The buy also coincides with a cluster pattern: 2 other insiders purchased within the past 14 days, suggesting broader management confidence despite deteriorating fundamentals and severe price deterioration. The concentration of this purchase into a deeply depressed valuation, combined with multi-insider buying activity during a period of sustained losses, warrants close monitoring of whether management's conviction in a turnaround has materialized.

CEO Dalton Travis bought 5,290 shares of CTEV at $47.23 (-37.7% from 52-week high); holding up 123.5%, clustering with 3 other insiders in past 14 days

Dalton Travis, the CEO, purchased 5,290 shares on 2025-11-20 at $47.23 for a total value of $249,841.94, increasing his holdings from 4,282 to 9,572 shares (a 123.5% increase). The purchase occurs at -37.7% from the 52-week high and follows sharp recent declines (-31.5% over 30 days, -37.3% over 90 days). His prior trades at CTEV show a consistent pattern of well-timed accumulation: all 4 prior buys registered positive 90-day returns (ranging from +4.2% to +165.6%), and his cross-ticker track record across 5 prior buys averaged +496.5% 90-day returns with a 100% win rate. The transaction is part of a cluster buy pattern, with 3 other insiders also purchasing within the past 14 days. Notably, the company is unprofitable, with $-69.8M net income in the latest quarter and -3.2% annual revenue growth, presenting a contrarian signal: concentrated insider accumulation during both a sharp stock decline and deteriorating fundamentals.